跳至主要内容
临床试验/NCT04143685
NCT04143685Unknown不适用

Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes

sammour.rami1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Vaginal delivery rate

研究概览

简要总结

This study compares the rate of vaginal delivery after induction of labor with misoprostol versus oxytocin in women with prelabor rupture of membranes. Participants will be randomized to receive either oral misoprotsol every four hours until going into labor, or intravenous oxytocin in increasing dose.

详细描述

Misoprostol is a synthetic prostaglandin analogue commonly used for labor induction. It causes uterine contractions and ripening of the cervix. Oxytocin sold under the brand name Pitocin among others, is a medication made from the peptide oxytocin and is used to cause contraction of the uterus to start labor.

This randomized controlled trial will compare induction of labor in women with term premature rupture of the membranes and unripe cervix using misoprostol versus oxytocin. The primary outcome is the rate of vaginal delivery. Secondary outcomes will include cesarean section rate, time interval from induction of labor to delivery, neonatal morbidity, patient satisfaction and side effects, as well as chorioamnionitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women in their 1st - 4th delivery
  • Term prelabor rupture of membranes (37+0 to 42+0 gestational age)
  • Vertex presentation
  • Singleton pregnancy

排除标准

  • Multiple pregnancy
  • Previous cesarean section
  • Chorioamnionitis on admission
  • >2 symptomatic uterine contractions in 10 minutes
  • Prostaglandins hypersensitivity
  • Contraindication for vaginal delivery

研究组 & 干预措施

misoprostol

Active Comparator

misoprostol 50 mcg tablet by mouth every four hours for maximum dosage of six

干预措施: Misoprostol (Drug)

oxytocin

Active Comparator

Oxytocin 10 IU in 1000 mL Standard solution. Starting with 10 mL/hr infusion rate and increasing by 10mL/hr every 20 minutes until achieving 3-5 regular uterine contractions every 10 minutes (as recorded by cardiotocography)

干预措施: Oxytocin (Drug)

结局指标

主要结局

Vaginal delivery rate

时间窗: During delivery

次要结局

  • Operative delivery rate, Cesarean section rate, time interval from induction of labor to delivery(During delivery)
  • chorioamnionitis rate(During or after delivery up to 7 days)
  • Uterine tachysystole(During delivery)
  • Neonatal morbidity(up to 7 days after delivery)

研究者

发起方
sammour.rami
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

sammour.rami

Head of Obstetrics

Bnai Zion Medical Center

研究点 (1)

Loading locations...

相似试验